Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- CheckyesterdayChange DetectedAdded content blocks for Study Status, Contacts/Locations, Eligibility, Outcome Measures, Study Description and Study Identification (versions 165–166) and introduced Revision: v3.3.4. Removed the 2025-12-31 entry and Revision: v3.3.3.SummaryDifference0.3%

- Check8 days agoChange DetectedA new version 164 was added on 2025-12-31, including updates to Study Status and Contacts/Locations.SummaryDifference0.1%

- Check16 days agoChange DetectedNew history entries (versions 160–163) with dates in December 2025 were added to the Record History, noting updates to Study Status.SummaryDifference0.3%

- Check23 days agoChange DetectedThe latest revision 3.3.3 (2025-12-23) adds new history entries to the page. The HHS Vulnerability Disclosure link and older revision v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check30 days agoChange DetectedNew history entries dated 2025-12-15 add Contacts/Locations and Study Status, with corresponding version entries 149–153 from 2025-12-06 to 2025-12-15, and a deletion on 2025-12-04.SummaryDifference0.5%

- Check37 days agoChange DetectedNew history entries were added on 2025-12-04 (version 148) to include Contacts/Locations and Study Status, with an earlier addition on 2025-12-02 (version 147). A deletion entry dated 2025-11-28 is also shown in the history.SummaryDifference0.2%

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.